BrainStorm Cell Therapeutics
BCLI
#10863
Rank
$8.71 M
Marketcap
$0.79
Share price
-1.25%
Change (1 day)
31.67%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -$9.57 Million USD

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -$10.31 Million USD, an increase over its 2024 earnings that were of -$11.63 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$9.57 Million-7.15%
2025 -$10.31 Million-11.32%
2024 -$11.63 Million-32.39%
2023 -$17.2 Million-29.18%
2022 -$24.28 Million-0.74%
2021 -$24.46 Million-23.12%
2020 -$31.82 Million36.8%
2019 -$23.26 Million66.71%
2018 -$13.95 Million181.66%
2017 -$4.96 Million-0.6%
2016 -$4.99 Million-41.31%
2015 -$8.49 Million-8.22%
2014 -$9.25 Million89.74%
2013 -$4.88 Million42.27%
2012 -$3.43 Million-12.45%
2011 -$3.92 Million63.04%
2010 -$2.4 Million35.52%
2009 -$1.78 Million-48.99%
2008 -$3.48 Million-44.39%
2007 -$6.25 Million
2005 -$3.24 Million-91.44%
2004 -$37.78 Million94007.62%
2003 -$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
$1.62 B-17,059.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$10.72 B-112,200.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-$0.8 Billion 8,160.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-$0.83 Billion 8,568.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$0.11 B-1,350.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-$0.26 Billion 2,569.69%๐Ÿ‡บ๐Ÿ‡ธ USA